Skip to content

Clinical trials

Lymphoma, T-Cell, Peripheral trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, T-Cell, Peripheral Country / region: Japan Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20113
20141
20164
20181
20191
20201
20212
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Bristol-Myers Squibb2
Eisai Co., Ltd.2
Solasia Pharma K.K.2
AstraZeneca1
Daiichi Sankyo1
Daiichi Sankyo Co., Ltd.1
Eisai Inc.1
HUYABIO International, LLC.1
Kyowa Kirin Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, T-Cell, Peripheral18
Lymphoma5
Leukemia-Lymphoma, Adult T-Cell4
Lymphoma, T-Cell, Cutaneous3
Recurrence3
Lymphoma, Non-Hodgkin2
Lymphoma, T-Cell2
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma2
Drug-Related Side Effects and Adverse Reactions1
Hodgkin Disease1

Trials

Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.